Cipronat tablets 500 mg

Form: Tablets
Dosage: 500mg
Packaging: 14 film-coated tablets

Antibiotic belonging to the fluorochinolone class

Active substance: ciprofloxacin

Form: film-coated tablet

Dosage:

Cipronat 250: 250 mg ciprofloxacin

Cipronat 500: 500 mg ciprofloxacin

Cipronat 750: 750 mg of ciprofloxacin

 

Packaging:

Box containing 14 tablets (each dosage)

 

Target: patients (adults and children) who require oral treatment with ciprofloxacin

Cipronat is indicated for the treatment of infections caused by bacteria sensitive to ciprofloxacin

  • Urinary and genital infections including infections due to Neisseria gonorrhoeae.

– Uretritis and cervicitis

– Gonorrhea (gonorrhoea)

– Orchi-epididymitis

  • Chronic bacterial prostatitis
  • Gastrointestinal and intra-abdominal infections (bacterial enteritis – traveller’s diarrhea – typhoid fever)
  • Skin and skin structure infections (Gram-negative bacteria)
  • Bone and joint infections (Gram negative)
  • Prophylaxis of meningitis (invasive Neisseria meningitidis infections)
  • Systemic Infection Inhalation anthrax (Gram negative)

Upper and lower respiratory infections (Ciprofloxacin is not the first choice for upper and lower respiratory infections)

– Acute sinusitis (due to Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis)

– Chronic purulent otitis media. Acute exacerbation of chronic sinusitis, especially due to Gram-negative bacteria.

– External malignant otitis

– exacerbations of chronic obstructive pulmonary disease, bronchopulmonary infections in cystic fibrosis or bronchiectasis, pneumonia.

Exception: Bronchopulmonary infections in cystic fibrosis, due to Pseudomonas aeruginosa.

The posology of Cipronat depends on:

  • the indication
  • the severity and location of the infection
  • the sensitivity of the pathogen(s) responsible
  • the renal function of the patient
  • and in children and adolescents the body weight.

The duration of treatment depends on the severity of the disease and the clinical and bacteriological evolution

 

For the majority of infections, a dosage of 500 mg or 750 mg twice daily is used for a period of 7 to 14 days

Treatment of infections due to certain germs may require higher doses of ciprofloxacin, as well as

Treatment of infections due to certain germs may require higher doses of ciprofloxacin, as well as the concomitant administration of other appropriate antibacterial agents.

Please refer to the SMPC for details of dosage and duration of treatment.

Prescription drugs. Please contact your doctor.

Notice of Trademark Infringement

Dear valued partners, customers and Dafra representatives,

It has come to our attention that unauthorized use of our company’s name and logo has been observed in various contexts in the African country Togo (https://www.dafrapharma-vet.com/). In order to avoid misunderstandings, ever misleading, we feel it is imperative to address this issue promptly and transparently.

Trademark infringement poses a significant threat not only to our brand integrity but also to the trust and credibility we have worked diligently to establish within our community. Our name and logo represent our values, quality, and commitment to excellence, and any unauthorized use undermines these principles.

We take trademark infringement seriously and are actively taking measures to address any instances of unauthorized use. This includes legal action against parties found to be infringing upon our intellectual property rights.

We urge our customers, partners, African representatives and the general public to remain vigilant and report any suspected instances of trademark infringement directly to us. Your cooperation in this matter is crucial in helping us protect our brand and preserve the integrity of our business.

As always, we remain dedicated to providing high quality medical solutions in the sub-Sahara region of Africa and maintaining the highest standards of integrity and professionalism.

Thank you for your continued support and trust in our company.

Dafra Pharma